Patents Assigned to Imagilin Technology, LLC
  • Patent number: 12171252
    Abstract: Compositions wherein foodstuffs act as carriers of freeze-dried probiotics provide new means for administration of probiotics. The products that are easily shipped may be eaten as purchased or mixed with other ingredients to provide variety in the diet while administering beneficial probiotic organisms to the gastrointestinal tract.
    Type: Grant
    Filed: March 18, 2019
    Date of Patent: December 24, 2024
    Assignee: IMAGILIN TECHNOLOGY, LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20190282498
    Abstract: Compositions wherein foodstuffs act as carriers of freeze-dried probiotics provide new means for administration of probiotics. The products that are easily shipped may be eaten as purchased or mixed with other ingredients to provide variety in the diet while administering beneficial probiotic organisms to the gastrointestinal tract.
    Type: Application
    Filed: March 18, 2019
    Publication date: September 19, 2019
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventor: Jhy-Jhu LIN
  • Patent number: 9789141
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Grant
    Filed: May 6, 2016
    Date of Patent: October 17, 2017
    Assignee: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Publication number: 20160243173
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Application
    Filed: May 6, 2016
    Publication date: August 25, 2016
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu LIN, Gen KATO, Takuo ISHIDA
  • Patent number: 9364507
    Abstract: This invention relates to use of probiotics, particularly P acidilactici and S boulardii, for use in conjunction with steroids and other immune suppressor agents to ameliorate symptoms of autoimmune diseases, especially disease symptoms arising from the body's production of antibodies against autologous blood cells. The practice of the invention sustains ameliorative response associated with immune suppressor agents while lowering the amount of immune suppressor agents required for treatment.
    Type: Grant
    Filed: August 11, 2010
    Date of Patent: June 14, 2016
    Assignee: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Publication number: 20140193464
    Abstract: A dry, stable and viable probiotic composition comprising, a probiotic microorganism and a dried plant powder, with the proviso that said composition is not a blended mixture of at least one biologically pure Pediococcus acidilactici probiotic culture and dried tomato powder at a weight ratio of 1:4 encapsulated in an effective amount in a gelatin capsule.
    Type: Application
    Filed: January 8, 2013
    Publication date: July 10, 2014
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventor: Jhy-Jhu Lin
  • Patent number: 8318152
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Grant
    Filed: April 16, 2009
    Date of Patent: November 27, 2012
    Assignee: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin
  • Publication number: 20110038838
    Abstract: Embodiment include methods for treating cats and dogs with inflammatory bowl disease or inflammatory-like bowl disease or immune mediated hemolytic anemia or atopic dermatitis which are being treated with steroids or immune suppressors which involves the step of administering to the animal a probiotic comprised of P. acidilactici and S. boulardii microorganisms for the purpose of reducing the amount of steroid or immune suppressor required to ameliorate the symptoms of the diseases or conditions.
    Type: Application
    Filed: August 11, 2010
    Publication date: February 17, 2011
    Applicant: IMAGILIN TECHNOLOGY, LLC
    Inventors: Jhy-Jhu Lin, Gen Kato, Takuo Ishida
  • Publication number: 20090263366
    Abstract: An exemplary embodiment providing one or more improvements includes probiotic compositions comprising probiotic microorganisms with dried vegetable, fruit, cereal, or herb powder. Feeding human or animals either having biological or environmental changes with probiotic compositions has a positive effect in relieving the changes. Positive effects has been demonstrated in humans, dogs, and fish.
    Type: Application
    Filed: April 16, 2009
    Publication date: October 22, 2009
    Applicant: Imagilin Technology, LLC
    Inventor: Jhy-Jhu Lin